Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Mycobacterium tuberculosis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
ANW-32821 |
Click to Show/Hide the Detail |
Drug ID |
DR2314
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Mycobacterium tuberculosis co-metabolize the drug ANW-32821, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
Drug ID |
DR0476
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Mycobacterium tuberculosis co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [2] |
Mycolicibacterium smegmatis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
ANW-32821 |
Click to Show/Hide the Detail |
Drug ID |
DR2314
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Mycolicibacterium smegmatis co-metabolize the drug ANW-32821, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [4] |
Streptomyces avermitilis (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Streptomyces avermitilis co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [5], [6] |
Testosterone cypionate |
Click to Show/Hide the Detail |
Drug ID |
DR1564
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Streptomyces avermitilis co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [7], [5] |
Bacteria: Bacteroidetes |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) metabolizes the drug Diclofenac sodium, and Bacteroides dorei further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Bacteria: Firmicutes |
Bacillus megaterium (firmicutes) |
Click to Show/Hide the Full List of Drugs: 4 Drugs Metabolized
|
Dextromethorphan hydrobromide |
Click to Show/Hide the Detail |
Drug ID |
DR0476
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Bacillus megaterium co-metabolize the drug Dextromethorphan hydrobromide, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [9] |
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Bacillus megaterium co-metabolize the drug Diclofenac sodium, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [10] |
Progesterone |
Click to Show/Hide the Detail |
Drug ID |
DR1346
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Bacillus megaterium co-metabolize the drug Progesterone, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [11] |
Testosterone cypionate |
Click to Show/Hide the Detail |
Drug ID |
DR1564
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Bacillus megaterium co-metabolize the drug Testosterone cypionate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [11], [12] |
Eubacterium coprostanoligenes (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
ANW-32821 |
Click to Show/Hide the Detail |
Drug ID |
DR2314
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) and Eubacterium coprostanoligenes co-metabolize the drug ANW-32821, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [13] |
Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) metabolizes the drug Diclofenac sodium, and Faecalibacterium prausnitzii further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Lactobacillus rhamnosus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) metabolizes the drug Diclofenac sodium, and Lactobacillus rhamnosus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Diclofenac sodium |
Click to Show/Hide the Detail |
Drug ID |
DR0488
Drug Info
|
Interaction Mechanism |
Human Cholesterol 24-hydroxylase (CYP46A1) metabolizes the drug Diclofenac sodium, and Ruminococcus gnavus further metabolizes its metabolite (Diclofenac glucuronide), which can indirectly affect efficacy, safety or bioavailability of this drug. |
[3], [8] |
|
|
|
|
|
|